Opdivo Use Expanded to Treat Lung Cancer
Drug Alerts , News / October 5, 2016

The FDA today expanded the approved use of Opdivo (nivolumab) to treat patients with advanced metastatic squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy. Opdivo works by inhibiting the cellular ...

Opdivo Approved for Advanced Melanoma
New Drugs , News / October 4, 2016

The FDA granted accelerated approval to Opdivo (nivolumab), a new treatment for patients with unresectable or metastatic melanoma who no longer respond to other drugs. Melanoma is a type of cancer forming in the body’s melanocyte cells, which deve...

Skip to toolbar